Back
Sutro Biopharma, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
54
STRO
Sutro Biopharma, Inc.
Last Price:
$12.31
Seasonality Move:
-14.43%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STRO is experiencing selling pressure, which indicates risk of future bearish movement.
Sutro Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.54 | Buy |
| 20-day SMA: | 10.69 | Buy |
| 50-day SMA: | 9.7 | Buy |
| 200-day SMA: | 8.78 | Buy |
| 8-day EMA: | 11.53 | Buy |
| 20-day EMA: | 10.81 | Buy |
| 50-day EMA: | 10.04 | Buy |
| 200-day EMA: | 11.61 | Buy |
Sutro Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 66.31 | Buy |
| Chaikin Money Flow: | -103681 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.18 - 11.44) | Buy |
| Bollinger Bands (100): | (8.31 - 10.63) | Buy |
Sutro Biopharma, Inc. Technical Analysis
| Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sutro Biopharma, Inc. Stock
Is Sutro Biopharma, Inc. Stock a Buy?
-
Sutro Biopharma, Inc. share price is 12.23 while STRO 8-day simple moving average is 11.54, which is a Buy signal.
-
The stock price of STRO is 12.23 while Sutro Biopharma, Inc. 20-day SMA is 10.69, which makes it a Buy.
-
Sutro Biopharma, Inc. 50-day simple moving average is 9.70 while STRO share price is 12.23, making it a Buy technically.
-
STRO stock price is 12.23 and Sutro Biopharma, Inc. 200-day simple moving average is 8.78, creating a Buy signal.
STRO Technical Analysis vs Fundamental Analysis
Buy
54
Sutro Biopharma, Inc. (STRO)
is a Buy
Is Sutro Biopharma, Inc. a Buy or a Sell?
-
Sutro Biopharma, Inc. stock is rated a BuyThe current Sutro Biopharma, Inc. [STRO] share price is $12.23. The Score for STRO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Sutro Biopharma, Inc. Stock Info
Market Cap:
104.2M
Price in USD:
12.23
Share Volume:
204.7K
Sutro Biopharma, Inc. 52-Week Range
52-Week High:
21.50
52-Week Low:
5.23
Buy
54
Sutro Biopharma, Inc. (STRO)
is a Buy
Sutro Biopharma, Inc. Share Price Forecast
-
What is the Sutro Biopharma, Inc. stock price today?The Sutro Biopharma, Inc. stock price is 12.23 USD today.
-
Will STRO stock go up or go down?Sutro Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Sutro Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sutro Biopharma, Inc. is not overvalued.
Is Sutro Biopharma, Inc. Stock a Buy?
-
Sutro Biopharma, Inc. share price is 12.23 while STRO 8-day exponential moving average is 11.53, which is a Buy signal.
-
The stock price of STRO is 12.23 while Sutro Biopharma, Inc. 20-day EMA is 10.81, which makes it a Buy.
-
Sutro Biopharma, Inc. 50-day exponential moving average is 10.04 while STRO share price is 12.23, making it a Buy technically.
-
STRO stock price is 12.23 and Sutro Biopharma, Inc. 200-day simple moving average is 11.61, creating a Buy signal.
Fundamental Analysis of Sutro Biopharma, Inc.
Is Sutro Biopharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.59 per share, and an increase next year of $10.41 per share.
Technical Analysis of Sutro Biopharma, Inc.
Should I short Sutro Biopharma, Inc. stock?
-
STRO Moving Average Covergence Divergence (MACD) indicator is 0.69, suggesting Sutro Biopharma, Inc. is a Buy
-
Sutro Biopharma, Inc. Relative Strength Index (RSI) is 66.31, which suggest Sutro Biopharma, Inc. is overbought
-
The Bollinger Bands (25) for Sutro Biopharma, Inc. is (9.18 - 11.44), which suggest Sutro Biopharma, Inc. is a Buy
-
The Bollinger Bands (100) for Sutro Biopharma, Inc. is (8.31 - 10.63), which suggest Sutro Biopharma, Inc. is a Buy
* Sutro Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.